Free Trial

Inovio Pharmaceuticals (INO) Earnings Date, Estimates & Call Transcripts

$11.31
+0.27 (+2.45%)
(As of 07/12/2024 08:51 PM ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 14Estimated
Actual EPS
(May. 13)
-$1.31 Missed By -$0.23
Consensus EPS
(May. 13)
-$1.08
Skip Charts & View Estimated and Actual Earnings Data

INO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

INO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Inovio Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($1.17)($1.17)($1.17)
Q2 20241($1.28)($1.28)($1.28)
Q3 20241($1.18)($1.18)($1.18)
Q4 20241($1.14)($1.14)($1.14)
FY 20244($4.77)($4.77)($4.77)
Q1 20251($1.16)($1.16)($1.16)
Q2 20251($1.07)($1.07)($1.07)
Q3 20251($0.99)($0.99)($0.99)
Q4 20251$1.20$1.20$1.20
FY 20254($2.02)($2.02)($2.02)

INO Earnings Date and Information

Inovio Pharmaceuticals last issued its earnings results on May 13th, 2024. The biopharmaceutical company reported ($1.31) earnings per share for the quarter, missing the consensus estimate of ($1.08) by $0.23. Inovio Pharmaceuticals has generated $0.00 earnings per share over the last year. Earnings for Inovio Pharmaceuticals are expected to grow in the coming year, from ($4.50) to ($3.16) per share. Inovio Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off prior year's report dates.

Inovio Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/14/2024
(Estimated)
------- 
5/13/2024Q1 2024($1.08)($1.31)($0.23)($1.31)$0.23 million-      
11/9/2023Q3 2023($18.72)($12.96)+$5.76($0.05)$0.18 million$0.39 million
8/9/2023Q2 2023($20.16)($18.72)+$1.44($0.13)$0.20 million$0.23 million    
5/10/2023Q1 2023($20.16)($23.04)($2.88)($0.16)$0.20 million$0.11 million    
3/1/2023Q4 2022($23.04)($31.68)($8.64)($0.21)$0.46 million$0.13 million      
11/8/2022Q3 2022($41.76)($21.60)+$20.16($0.15)$0.53 million$9.15 million      
8/9/2022Q2 2022($43.20)($66.24)($23.04)($0.46)$0.52 million$0.78 million    
5/10/2022Q1 2022($40.32)($51.84)($11.52)($0.36)$0.66 million$0.20 million    
3/1/2022Q4 2021($47.52)($72.00)($24.48)($0.50)$0.55 million$0.84 million    
11/9/2021Q3 2021($47.52)($41.76)+$5.76($0.29)$0.19 million$0.29 million    
8/9/2021Q2 2021($36.00)($56.16)($20.16)($0.39)$1.21 million$0.27 million    
5/10/2021Q1 2021($25.92)($38.88)($12.96)($0.27)$1.06 million$0.40 million  
2/28/2021Q4 2020($31.68)($20.16)+$11.52($0.14)$1.22 million$5.60 million    
11/9/2020Q3 2020($27.36)$15.84+$43.20($0.55)$3.05 million$0.24 million  
8/10/2020Q2 2020($24.48)($119.52)($95.04)($0.37)$2.61 million$0.20 million  
5/11/2020Q1 2020($31.68)($37.44)($5.76)($0.26)$1.55 million$1.33 million    
3/12/2020Q4 2019($34.56)($54.72)($20.16)($0.26)$1.36 million$0.28 million    
11/12/2019Q3 2019($37.44)($36.00)+$1.44($0.29)$2.72 million$0.87 million    
8/8/2019Q2 2019($40.32)($43.20)($2.88)($0.30)$4.69 million$0.14 million  

Inovio Pharmaceuticals Earnings - Frequently Asked Questions

When is Inovio Pharmaceuticals's earnings date?

Inovio Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off last year's report dates. Learn more on INO's earnings history.

Did Inovio Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Inovio Pharmaceuticals (NASDAQ:INO) missed the analysts' consensus estimate of ($1.08) by $0.23 with a reported earnings per share (EPS) of ($1.31). Learn more on analysts' earnings estimate vs. INO's actual earnings.

How can I listen to Inovio Pharmaceuticals's earnings conference call?

The conference call for Inovio Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call

How can I read Inovio Pharmaceuticals's conference call transcript?

The conference call transcript for Inovio Pharmaceuticals's latest earnings report can be read online. Read Transcript

How can I view Inovio Pharmaceuticals's earnings report?

Inovio Pharmaceuticals's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does Inovio Pharmaceuticals generate each year?

Inovio Pharmaceuticals (NASDAQ:INO) has a recorded annual revenue of $830,000.00.

How much profit does Inovio Pharmaceuticals generate each year?

Inovio Pharmaceuticals (NASDAQ:INO) has a recorded net income of -$135.12 million. INO has generated $0.00 earnings per share over the last four quarters.

What is Inovio Pharmaceuticals's EPS forecast for next year?

Inovio Pharmaceuticals's earnings are expected to grow from ($4.50) per share to ($3.16) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:INO) was last updated on 7/15/2024 by MarketBeat.com Staff

From Our Partners